About DIA 2014
The DIA 2014 50th Annual Meeting is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines involved in the discovery, development, and life cycle management of medical products all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.
DIA 2014 50th Annual Meeting will:
- Provide a global unbiased platform to raise the level of discussion to facilitate innovation that will change the future of health care
- Provide comprehensive coverage of the full development and life cycle management of process for all health care products
- Offer a holistic and integrated approach to the development life cycle management of regulated health care products
DIA 2014 50th Annual Meeting provides the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.
Who Should Attend?
This meeting is designed for individuals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related medical products. The Annual Meeting is intended to strengthen professionals’ understanding of the value of cross-discipline integration and to foster innovation for better health outcomes.
How to Register
We offer four easy ways to register for the DIA 2014 50th Annual Meeting- Online, Phone, FAX or Mail.
Sign-up online- it's the quickest way to register.
+1.215.442.6100 or toll free at +1.888.257.6457 (Mon-Fri, 8:30AM-8PM ET)
Registration form (PDF) to +1.215.442.6199
Drug Information Association
P.O. Box 421
Annapolis Junction, MD 20701
(Note: Checks must be drawn on U.S. bank)
Need to justify your attendance to your employer? Download the attendance justification letter.
Group Registration Available!
Register 10 individuals and receive a complimentary registration. Note: Reduced registration fees do not qualify for group registration. Contact CustomerService@DIAHome.org for details.
- Member Standard
- Member Charitable Nonprofit/Academia
- Member Government
- One-Day Member
- NonMember Standard
- One-Day Nonmember
- NonMember Charitable Nonprofit/Academia
- NonMember Government
Registration Fees for Additional Offerings
- #20: Japan Regulatory Environment: Overview - Standard Rate
- #21: The Sunshine Act - Standard Rate
- #22: Preparing for a US FDA Advisory Committee Meeting - Standard Rate
- #23: Leadership: How to Organize and Lead People - Standard Rate
- #24: Successful Drug Development: Best Practices - Standard Rate
- #30: Influencing Culture, Avoiding Bureaucracy and Encouraging Innovation - Standard Rate
- #31: Large-Scale Regulatory Functional Outsourcing - Standard Rate
- #32: Pharmacogenomics and Companion Diagnostics - Standard Rate
- #33: Bayesian Evidence Synthesis and Network Meta-analysis - Standard Rate
- #34: Preparation of REMS Assessment Reports - Standard Rate
- #35: Understanding Translational Medicine - Standard Rate
- #40: Analysis of Safety Data from Clinical Trials - Standard Rate
- #41: Quality Oversight of CROs-Clinical Vendors - Standard Rate
- #42: Regulatory Affairs for Biologics - Standard Rate
- #43: Clinical Statistics for Nonstatisticians - Standard Rate
- #44: Quality by Design From Theory to Practice - Standard Rate
- #45: Risk Management Plan - Standard Rate
- #46: The Good Pharmacovigilance Practices In The E - Standard Rate
Call for Posters!
Call for Student Poster Abstracts
The Student Poster Program is an opportunity for eligible students to present research results to a diverse group of scientific professionals who are actively involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and healthcare related products.
Deadline: Monday, March 24*
| Student Verification Form
| Submit an Abstract
See page 2 of the Abstract Guidelines for a student poster abstract template and sample poster abstract.
*Deadline will not be extended
Questions related to the Call for Abstracts can be sent to email@example.com
Poster Highlights from the DIA 2013 49th Annual Meeting!
We like to take the opportunity to thank the 60+ Professional Poster Presenters that presented their work in this year’s Annual Meeting Program.
Read Professional Poster abstracts from the DIA 2013 49th Annual Meeting Program included in the next issue of the Global Forum
New this year, Annual Meeting Attendees were asked to select the top 3 Professional Posters from this year’s program.
Results are in! Congratulations to those selected!
Current Scenario of Clinical Research Sites in Thailand: A Ground Up Approach to Clinical Site Selection in Emerging Countries
Lisa Maire Saldanha
Director- Feasibility & Site Identification (South East Asia, Korea, ANZ)
Quintiles East Asia Pte. Ltd., Singapore
Inspections: Streamlining Backstage Operations Using the Cloud
Suvarna Lakshmi Jetti
Genentech, A Member of the Roche Group
Anxiolytic-like Effect of Beta Receptor Agonist Amibegron May be Related to Interaction of Serotonin Receptor Subtypes
Pelin Tanyeri, MD
Sakarya University Medical Faculty, Turkey
View Professional Posters
from the DIA 2013 49th
Annual Meeting Program
Twenty students from all of the world joined us in Boston to present their original research in this year’s program. Student Poster winners (1st, 2nd and 3rd place winners) were announced and recognized on Monday, June 24, please join us in congratulating this year’s student poster presenters!
Evaluation of Cytochrome P450 2C19 Activity in Normal, Healthy Adult Subjects in a Western Indian Population
Harshavardhan Narendra Sant
Seth G.S. Medical College and K.E.M. Hospital, Parel, Mumbai, Maharashtra, India
Challenges in Discovery and Development of Orphan Drugs and Possible Solutions: Indian Scenario
Priti Padmakar Pednekar MPharm,
Bharati Vidyapeeth's College of Pharmacy, University of Mumbai, India
The Registration of Biosimilar Medicines: The Case of Low Molecular Weight Heparines in View of the New CHMP Guideline
Anna Magdalena Perelka
Medical University of Warsaw, Poland
DIA 2013 Highlights
Take a Sneak Peak...
Monday, June 24 | Tuesday, June 25 | Wednesday, June 26
White Papers Featured at DIA 2013 49th Annual Meeting in Boston, MA
Next Generation Medical Information Call Center by
Benefits of Trial Data Transparency and Sharing
DIA 49th Annual Meeting Session Reports
Monday, June 24
View Session 119. Hot Topics in Statistics: Working Together Effectively to Transform Our Science
View Session 123. How Can Translational Medicine Fill The Gaps in Life Sciences Industries?
View Session 130. Translational Aspects from Preclinical Animal Toxicology Studies to Early Human Health Risk Assessment: Needs and Limitations
View Session 143. Key Multiplicity Issues in Clinical Trial
View Session 144. The Secret of Stellar Careers: Serendipity + Planning = Success
Tuesday, June 25
View Session 220. Biomarkers for Drug Development: How are we dealing with the challenges?
View Session 234. Strategies for the Development and Registration of Antibody Drug Conjugates
View Session 239. Student Forum: Getting a Job & Developing a Career
View Session 262. First-in-Human Studies: How Much Complexity Is Too Much?
View Session 277. Short Breakthrough Status
Wednesday, June 26
View Session 318. Molecular Predictors of Drug Induced Harm: From Clinical Development to Postmarketing Surveillance
View Session 332. Pharmacometrics: Implications and Impact in Preclinical to Early Phase Development
View Session 339. Drug Shortages: Causes, Current State & Path Forward
View Session 343. Challenges and Strategic Approaches to Biosimilar Development
View Session 360. Rising to the Challenge of Developing Novel Orphan Medicines for the Global Market
View Annual Meeting Student Reflections
EMA Press Release: Pharmacovigilance Risk Assessment Committee: One year of Public Health Promotion and Protection
From the News
DIA panel discusses collaboration to improve drug trials by Don Sieffert, Boston Business Journal
Here are 9 industry insiders at DIA 2013 to follow on Twitter by Stephanie Baum, MedCity News
Backlog to the Future: DIA 2013 in pictures by Gareth Macdonald
Final Count for One Fund Boston Contributions - Thank you DIA Attendees!
DIA 2013 Boston Recap from the BioClinica Exhibit by Jennifer Price
Delegation from Taiwan for the DIA 2013 49th Annual Meeting
49th Annual DIA Meeting Boston
Unable to Attend DIA 2013 49th Annual Meeting?
live recordings from this year’s Annual Meeting.
DIA 2013 49th Annual Meeting Photo Library
Tribute to Boston at the DIA 2013 49th Annual Meeting